Left atrial appendage resection during thoracoscopic ablation in patients with atrial fibrillation: an own experience
Abstract
Aim . To improve the quality of high-tech health care provided to patients with atrial fibrillation (AF) by performing left atrial appendage (LAA) resection with an endoscopic stapler during thoracoscopic isolation of left atrial (LA) arrhythmogenic zones. Material and methods . This article presents the surgical outcomes of patients with AF who underwent LAA resection with an endoscopic stapler during thoracoscopic isolation of LA arrhythmogenic zones. The stapler is a device suturing tissue with staples followed by resection. The treatment period lasted 2023-2025. The outcomes were assessed in 2025. Ninety-two patients were treated, with LAA resection performed in 43 (47%). Thus, two groups of patients were formed: group 1 — patients who underwent LAA resection; group 2 — patients who did not undergo LAA resection. Results . All LAA resections performed with an endoscopic stapler were not accompanied by any complications during the procedure, as well as cardiac strokes in all patients during this follow-up period. The study demonstrates the freedom from AF recurrence in patients in the endoscopic LAA resection group. Conclusion . LAA resection is an important component of thoracoscopic ablation aimed at preventing stroke and thromboembolic events in patients with AF. The use of an endoscopic stapler allows for LAA resection with minimal risk of complications, significantly increasing the effectiveness of radiofrequency ablation.